Glycerol phenylbutyrate
Clinical data | |
---|---|
Trade names | Ravicti |
AHFS/Drugs.com | ravicti |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | A16AX09 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 611168-24-2 |
PubChem (CID) | 10482134 |
DrugBank | DB08909 |
ChemSpider | 8657541 |
ChEMBL | CHEMBL2105745 |
ECHA InfoCard | 100.228.552 |
Chemical and physical data | |
Formula | C33H38O6 |
Molar mass | 530.651 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.[1]
References
This article is issued from Wikipedia - version of the 9/4/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.